• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

It is over April 11th - and here is why!

Quote

anonymous

Guest
CMS Prevents Doctors From Profiting Off Aduhelm | InsideHealthPolicy.com

MS has chosen a reimbursement metric that prevents doctors from making money from prescribing Aduhelm, and it will likely result in doctors losing money each time they administer the Alzheimer’s drug once sequestration takes effect. Starting April 1, CMS plans to insert the new metric into the Part B formula to bring doctor reimbursement in line with the huge Aduhelm price cut that took effect Jan. 1, according to a CMS notice, but the agency could’ve used a different metric

Biogen doesn't want customers to know this dirty little secret...

They will lose money, even if reimbursed, starting April 1. WAMP

CMS plans to stick with their guns. Expect it to be all over week of April 11th.
 




No one will make any money off of this infusion. What you will find in the next one to 2 weeks, all infusion locations will state they will no longer infuse this drug. Come April 1, they will actually lose money if they infuse Aduhelm. Expect Layoff in 14-17 days.
 




anonymous said:
No one will make any money off of this infusion. What you will find in the next one to 2 weeks, all infusion locations will state they will no longer infuse this drug. Come April 1, they will actually lose money if they infuse Aduhelm. Expect Layoff in 14-17 days.
Click to expand...
Yes - it is a lot like Sloe Joe making gas unaffordable for everyone - his idiocy and policies are not “making” you go green, but him tripling prices (and then some) makes it almost necessary
 








Top Bottom
Back
Quote